These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 6460184

  • 41. Foxp3 expression in lesions of the different clinical forms of American tegumentary leishmaniasis.
    Carneiro FP, De Magalhães AV, De Jesus Abreu Almeida Couto M, Bocca AL, Muniz-Junqueira MI, Ribeiro Sampaio RN.
    Parasite Immunol; 2009 Oct; 31(10):646-51. PubMed ID: 19751477
    [Abstract] [Full Text] [Related]

  • 42. Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated.
    Carvalho EM, Bacellar O, Barral A, Badaro R, Johnson WD.
    J Clin Invest; 1989 Mar; 83(3):860-4. PubMed ID: 2522103
    [Abstract] [Full Text] [Related]

  • 43. Diffuse cutaneous leishmaniasis in Ethiopia. 3. Immunological studies. IV. Pathogenesis of diffuse cutaneous leishmaniasis.
    Bryceson AD.
    Trans R Soc Trop Med Hyg; 1970 Mar; 64(3):380-93. PubMed ID: 4195254
    [No Abstract] [Full Text] [Related]

  • 44. Leishmaniasis in Brazil: X. Some observations of intradermal reactions to different trypanosomatid antigens of patients suffering from cutaneous and mucocutaneous leishmaniasis.
    Shaw JJ, Lainson R.
    Trans R Soc Trop Med Hyg; 1975 Mar; 69(3):323-35. PubMed ID: 52214
    [Abstract] [Full Text] [Related]

  • 45. Quantification of Leishmania-specific T cells in human American cutaneous leishmaniasis (Leishmania braziliensis braziliensis) by limiting dilution analysis.
    Dórea RC, Coutinho SG, Sabroza PC, Hendriks J, Cysne L, Conceição-Silva F.
    Clin Exp Immunol; 1988 Jan; 71(1):26-31. PubMed ID: 3258203
    [Abstract] [Full Text] [Related]

  • 46. Evaluation of T-cell subsets in the lesion infiltrates of human cutaneous and mucocutaneous leishmaniasis.
    Barral A, Jesus AR, Almeida RP, Carvalho EM, Barral-Netto M, Costa JM, Badaro R, Rocha H, Johnson WD.
    Parasite Immunol; 1987 Jul; 9(4):487-97. PubMed ID: 2957642
    [Abstract] [Full Text] [Related]

  • 47. Characterization of in vitro proliferative responses of human lymphocytes to leishmanial antigens.
    Wyler DJ, Weinbaum FI, Herrod HR.
    J Infect Dis; 1979 Aug; 140(2):215-21. PubMed ID: 90105
    [Abstract] [Full Text] [Related]

  • 48. Cutaneous leishmaniasis in Ethiopia: I. Lymphocyte transformation and antibody titre.
    Schurr E, Kidane K, Yemaneberhan T, Wunderlich F.
    Trop Med Parasitol; 1986 Dec; 37(4):403-8. PubMed ID: 3563321
    [Abstract] [Full Text] [Related]

  • 49. Alterations of the immune response associated with chronic experimental leishmaniasis.
    Arredondo B, Pérez H.
    Infect Immun; 1979 Jul; 25(1):16-22. PubMed ID: 157979
    [Abstract] [Full Text] [Related]

  • 50. Mechanisms of protective immunity in experimental cutaneous leishmaniasis of the guinea-pig. III. Inhibition of leishmanial lesion in the guinea-pig by delayed hypersensitivity reaction to unrelated antigens.
    Behin R, Mauel J, Rowe DS.
    Clin Exp Immunol; 1977 Aug; 29(2):320-5. PubMed ID: 908177
    [Abstract] [Full Text] [Related]

  • 51. Experimental cutaneous leishmaniasis: disseminated leishmaniasis in genetically susceptible and resistant mice.
    Scott PA, Farrell JP.
    Am J Trop Med Hyg; 1982 Mar; 31(2):230-8. PubMed ID: 6462064
    [No Abstract] [Full Text] [Related]

  • 52. Regulatory T-Cell Dynamics in Cutaneous and Mucocutaneous Leishmaniasis due to Leishmania braziliensis.
    Barros N, Vasquez N, Woll F, Sanchez C, Valencia B, Llanos-Cuentas A, White AC, Montes M.
    Am J Trop Med Hyg; 2018 Mar; 98(3):753-758. PubMed ID: 29405108
    [Abstract] [Full Text] [Related]

  • 53. The clinical and immunological spectrum of American cutaneous leishmaniasis.
    Convit J, Ulrich M, Fernández CT, Tapia FJ, Cáceres-Dittmar G, Castés M, Rondón AJ.
    Trans R Soc Trop Med Hyg; 1993 Mar; 87(4):444-8. PubMed ID: 8249076
    [Abstract] [Full Text] [Related]

  • 54. Host and parasite factors influencing the expression of cutaneous leishmaniasis.
    Sher A, Sacks DL, Scott PA.
    Ciba Found Symp; 1983 Mar; 99():174-89. PubMed ID: 6227463
    [Abstract] [Full Text] [Related]

  • 55. Cutaneous leishmaniasis: immune complex formation and necrosis in the acute phase.
    Ridley MJ, Ridley DS.
    Br J Exp Pathol; 1984 Jun; 65(3):327-36. PubMed ID: 6378241
    [Abstract] [Full Text] [Related]

  • 56. Leishmaniasis in Brazil. XIV. Leishmanial and trypanosomal IgA antibody in patients with leishmaniasis and Chagas's disease.
    Shaw JJ, Lainson R.
    Trans R Soc Trop Med Hyg; 1981 Jun; 75(2):254-7. PubMed ID: 6795770
    [Abstract] [Full Text] [Related]

  • 57. In situ characterization of the cellular immune response in American cutaneous leishmaniasis.
    Modlin RL, Tapia FJ, Bloom BR, Gallinoto ME, Castes M, Rondon AJ, Rea TH, Convit J.
    Clin Exp Immunol; 1985 May; 60(2):241-8. PubMed ID: 3159527
    [Abstract] [Full Text] [Related]

  • 58. [On 113 cases of cutaneous leishmaniasis and mucocutaneous leishmaniasis observed in Bolivia. Sero-immunologic study of 71 cases].
    Desjeux P, Quilici M, Lapierre J.
    Bull Soc Pathol Exot Filiales; 1974 May; 67(4):387-95. PubMed ID: 4480529
    [No Abstract] [Full Text] [Related]

  • 59. T-cell responses to infected autologous monocytes in patients with cutaneous and mucocutaneous leishmaniasis.
    Cooper AM, Melby PC, Karp CL, Neva F, Sacks DL.
    Clin Diagn Lab Immunol; 1994 May; 1(3):304-9. PubMed ID: 7496967
    [Abstract] [Full Text] [Related]

  • 60. Atypical mucocutaneous leishmaniasis caused by Leishmania braziliensis in an acquired immunodeficiency syndrome patient: T-cell responses and remission of lesions associated with antigen immunotherapy.
    Da-Cruz AM, Filgueiras DV, Coutinho Z, Mayrink W, Grimaldi G, De Luca PM, Mendonca SC, Coutinho SG.
    Mem Inst Oswaldo Cruz; 1999 May; 94(4):537-42. PubMed ID: 10446016
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.